12-Valent Pneumococcal Conjugate Vaccine
Protocol ASCLIN 002/2022
Phase 3 mab active
Quick answer
12-Valent Pneumococcal Conjugate Vaccine for Pneumococcal Vaccines is a Phase 3 program (mab) at MAIA Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- MAIA Biotechnology
- Indication
- Pneumococcal Vaccines
- Phase
- Phase 3
- Modality
- mab
- Status
- active